Safety and Cardiovascular Efficacy of Spironolactone in Dialysis-Dependent ESRD Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The SPin-D Trial is a phase II randomized, double-blind, placebo-controlled, multi-center study of spironolactone (SPL) for patients with hemodialysis-dependent end-stage renal disease.
Epistemonikos ID: 9b374045b1050c0f0c6dbd22fa7c749bfd895086
First added on: May 12, 2024